the acoustic startle reflex. These authors found PPI disruption in patients with bipolar disorder only if they are male and depressed, suggesting that this behavioral phenotype is both trait-and state-specific. The same group of investigators also report that weak handgrip strength and high body mass index are disadvantageous for cognitive function in patients with schizophrenia (Relationship of Handgrip Strength and Body Mass Index With Cognitive Function in Patients With Schizophrenia by Hidese et al.) , providing a potential physical index for cognitive performance. Much attention has been paid to early intervention into cognitive and social outcomes in psychosis. This topic was reviewed in Early Intervention and a Direction of Novel Therapeutics for the Improvement of Functional Outcomes in Schizophrenia: A Selective Review by Kurachi et al., who summarized evidence for morphological changes in the brains of individuals with schizophrenia, and provides perspectives of novel treatments. In an effort to develop effective therapeutics for cognitive impairment, translational approaches, i.e., bridging preclinical and clinical evidence, have been attempted. However, clinical trials of agents, produced through such approaches, have yielded negative results in most cases, indicating a need for further study. Receptors and Their Effects on Place Navigation). In addition to these agents, neurotrophic compounds, anti-inflammatory/ oxidation agents, and particular nutrients may provide a novel candidate for pharmaco-therapeutics in this field. Also, whether prolonged administration of antipsychotic drugs is advantageous for improving cognition social function in schizophrenia and early psychoses has attracted attention. Accordingly, Omachi and Sumiyoshi examined results from relevant studies on this issue in Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes, which should provide a clue to improving long-term consequences of quality of life for patients.
There is also a growing trend to develop non-pharmacologic therapeutics for ameliorating cognitive deficits in psychiatric illnesses. In particular, promising results have been reported for several types of cognitive remediation, or rehabilitation in schizophrenia and other diseases. Mogami contributed an Opinion on the Neuropsychological Educational Approach to Remediation (NEAR), one of the landmark methods of cognitive training (Cognitive Remediation for Schizophrenia with Focus on NEAR). Efficacy of this type of cognitive rehabilitation has been reported mainly for relatively young people with schizophrenia. With a well-controlled study design, Choi et al. found that disturbances of some of the key cognitive domains were alleviated also in older patients with chronic schizophrenia Impaired cognitive function has also been suggested to underline some aspects of the psychopathology of eating disorders. Thus, Tamiya et al. compared cognitive profiles between the restricting type and binge-eating/purging type of anorexia nervosa, and found significantly worse attention/ vigilance for the latter type, which may be related to the higher mortality rate (Neurocognitive Impairments Are More Severe in the Binge-Eating/Purging Anorexia Nervosa Subtype Than in the Restricting Subtype).
These days, we occasionally receive a message "Tomiki (Kenji), an article you edited reached an impact milestone. " At the time of completion of this Editorial, the number of "views" of our Topic has reached almost 73,000, thanks greatly to the dedicated authors worldwide. This status assures us that our endeavor to "make a forum for researchers and clinicians interested in cognitive impairment of psychiatric illnesses" has been attained. This collaborative work accomplished by our colleagues will help facilitate the development of therapeutics of greater clinical value.
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